Glimshine MP 2mg/500mg/7.5mg Tablet SR
Marketer
Shinemax Pharma India Pvt Ltd
Salt Composition
Glimepiride (2mg) + Metformin (500mg) + Pioglitazone (7.5mg)
Overview Glimshine MP 2mg/500mg/7.5mg Tablet SR
Diabetic patients using GlycoBalance XR 2mg/500mg/7.5mg extended-release tablets can achieve better blood glucose management. This triple-action formulation, used alongside diet and exercise, improves insulin utilization in adults with type 2 diabetes. Dosage and frequency should strictly follow your physician's instructions; always take it with food to prevent gastrointestinal discomfort. Missed doses should be taken promptly unless the next dose is imminent; never double the dose. Excessive intake can cause dangerously low blood sugar (hypoglycemia). Concurrent use with other diabetes medications, alcohol, or skipped meals increases the hypoglycemia risk; regular blood sugar monitoring is crucial. Common side effects may include nausea, diarrhea, abdominal pain, headache, increased bone fracture risk, and respiratory infections. Prior to starting GlycoBalance XR, disclose any kidney, liver, or heart conditions to your doctor. Pregnant or lactating individuals require medical consultation. Kidney function tests will be performed before commencing treatment. Limit alcohol consumption to minimize the potential for adverse reactions.
Uses of Glimshine MP 2mg/500mg/7.5mg Tablet SR
Managing type 2 diabetes
Major Benefits of Glimshine MP 2mg/500mg/7.5mg Tablet SR:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the entire tablet; do not crush, chew, or break it. Glimshine MP 2mg/500mg/7.5mg Sustained-Release tablets should be administered with food.
Common Side effects of Glimshine MP 2mg/500mg/7.5mg Tablet SR:
- Hypoglycemia (low blood glucose level)
- Headache
- Nausea
- Diarrhea
- Dizziness
- Vomiting
- Anemia (low number of red blood cells)
- Weakness
- Sinus infection
How to use Glimshine MP 2mg/500mg/7.5mg Tablet SR:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment duration. Ingest the entire tablet without chewing, crushing, or dividing it. The Glimshine MP 2mg/500mg/7.5mg Extended-Release tablet should be taken with meals.
How Glimshine MP 2mg/500mg/7.5mg Tablet SR works:
Glimshine MP 2mg/500mg/7.5mg Extended-Release tablets combine glimepiride, metformin, and pioglitazone—three distinct antidiabetic agents. This triple therapy enhances blood sugar management when single or dual drug regimens prove insufficient. Glimepiride, a sulfonylurea, stimulates pancreatic insulin release to reduce blood glucose. Metformin, a biguanide, acts through multiple pathways: decreasing hepatic glucose production, slowing intestinal glucose absorption, and improving insulin responsiveness. Pioglitazone, a thiazolidinedione, complements this action by further augmenting insulin sensitivity.
SAFETY ADVICE
AlcoholUNSAFE
Consuming alcohol while taking Glimshine MP 2mg/500mg/7.5mg SR tablets is unsafe.
PregnancyCONSULT YOUR DOCTOR
The use of Glimshine MP 2mg/500mg/7.5mg SR tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the potential benefits against any risks before prescribing this medication. Seek medical advice before using this drug.
Breast feedingCONSULT YOUR DOCTOR
The extended-release Glimshine MP 2mg/500mg/7.5mg tablet is likely unsuitable for breastfeeding mothers. Available human data indicates potential transfer to breast milk, posing a possible risk to the infant.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.
KidneyCAUTION
Exercise caution when prescribing Glimshine MP 2mg/500mg/7.5mg SR tablets to individuals with impaired renal function; dosage modification may be necessary. Patients with severe kidney disease should not receive this medication. Close monitoring of kidney function is recommended during treatment. Consult a physician for guidance.
LiverCAUTION
Exercise caution when prescribing Glimshine MP 2mg/500mg/7.5mg Tablet SR to individuals with hepatic impairment; dosage modification may be necessary. Physician consultation is advised. Glimshine MP 2mg/500mg/7.5mg Tablet SR is contraindicated in patients exhibiting severe liver dysfunction.
What if you forget to take Glimshine MP 2mg/500mg/7.5mg Tablet SR :
Should you forget to take your Glimshine MP 2mg/500mg/7.5mg Tablet SR, administer it immediately upon remembrance. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Glimshine MP 2mg/500mg/7.5mg Tablet SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Type of Therapy | Diabetes Management |
3,018 People bought this recently